Submission Details
| 510(k) Number | K233403 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 04, 2023 |
| Decision Date | April 30, 2024 |
| Days to Decision | 209 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K233403 is an FDA 510(k) clearance for the Flexset System, a Full-montage Standard Electroencephalograph (Class II — Special Controls, product code GWQ), submitted by Zeto, Inc. (Raleigh, US). The FDA issued a Cleared decision on April 30, 2024, 209 days after receiving the submission on October 4, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K233403 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 04, 2023 |
| Decision Date | April 30, 2024 |
| Days to Decision | 209 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GWQ — Full-montage Standard Electroencephalograph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations |